Saul Faust on SPVX02, room-tempature-stabilised tetanus-diptheria vaccine

Saul Faust joins Senior Editor Owen Stretton to talk about his team’s phase 1 trial on SPVX02, a lyophilised, fridge-free version of the Tetadif tetanus-diphtheria vaccine, and its potential in increasing vaccination coverage.

Click here to read the full article:

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00369-X/fulltext